Emergent BioSolutions Inc. financial data

Symbol
EBS on NYSE
Location
300 Professional Dr, Gaithersburg, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 107 % -15.7%
Quick Ratio 52 % +10.5%
Debt-to-equity 193 % +55.2%
Return On Assets -33.4 % -55.2%
Operating Margin -40.8 % +19.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.9M shares +2.12%
Common Stock, Shares, Outstanding 52.9M shares +2.12%
Entity Public Float 381M USD -74.6%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 52.6M shares +3.75%
Weighted Average Number of Shares Outstanding, Diluted 52.6M shares +3.75%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.1B USD +2.79%
Research and Development Expense 92.5M USD -41.8%
Operating Income (Loss) -450M USD +16.9%
Nonoperating Income (Expense) -129M USD -7659%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -578M USD -6.43%
Income Tax Expense (Benefit) 8.9M USD -84.1%
Net Income (Loss) Attributable to Parent -587M USD +2.44%
Earnings Per Share, Basic -11.2 USD/shares +6.44%
Earnings Per Share, Diluted -11.2 USD/shares +6.44%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 69.7M USD -21.3%
Accounts Receivable, after Allowance for Credit Loss, Current 196M USD -32.3%
Inventory, Net 318M USD -10.4%
Assets, Current 655M USD -15.8%
Property, Plant and Equipment, Net 306M USD -22.6%
Operating Lease, Right-of-Use Asset 13.7M USD -12.7%
Intangible Assets, Net (Excluding Goodwill) 534M USD -9.9%
Goodwill 0 USD -100%
Other Assets, Noncurrent 18.7M USD -90.4%
Assets 1.51B USD -30.5%
Accounts Payable, Current 95.9M USD -11.5%
Employee-related Liabilities, Current 66.7M USD -4.17%
Accrued Liabilities, Current 17.2M USD -44.9%
Contract with Customer, Liability, Current 6.2M USD -56.6%
Liabilities, Current 620M USD -10.6%
Contract with Customer, Liability, Noncurrent 5.9M USD -88.8%
Deferred Income Tax Liabilities, Net 34.8M USD -39.9%
Operating Lease, Liability, Noncurrent 11.5M USD -12.2%
Other Liabilities, Noncurrent 25.7M USD +9.83%
Liabilities 1.13B USD -7.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.5M USD -244%
Retained Earnings (Accumulated Deficit) -296M USD -202%
Stockholders' Equity Attributable to Parent 386M USD -59.7%
Liabilities and Equity 1.51B USD -30.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -62.6M USD +66%
Net Cash Provided by (Used in) Financing Activities 40.7M USD
Net Cash Provided by (Used in) Investing Activities -10.8M USD +28.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 58.5M shares +1.92%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -32.7M USD +84.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 71M USD -19.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 21.5M USD -0.46%
Deferred Tax Assets, Valuation Allowance 258M USD +296%
Deferred Tax Assets, Gross 270M USD +106%
Operating Lease, Liability 14.6M USD -12.6%
Depreciation 49M USD -32.6%
Payments to Acquire Property, Plant, and Equipment 10.8M USD -28.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -591M USD +0.62%
Lessee, Operating Lease, Liability, to be Paid 20.4M USD -13.2%
Property, Plant and Equipment, Gross 707M USD -10.2%
Operating Lease, Liability, Current 3.1M USD -13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.7M USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.3M USD -33.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +22.2%
Deferred Income Tax Expense (Benefit) 1.9M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.1M USD +6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.9M USD +7.41%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 6.6M USD -2.94%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.3M USD 0%
Additional Paid in Capital 915M USD +2.18%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 65M USD 0%
Depreciation, Depletion and Amortization 27.9M USD -19.4%
Deferred Tax Assets, Net of Valuation Allowance 11.7M USD -82.2%
Share-based Payment Arrangement, Expense 19.4M USD -48.9%
Interest Expense 94.3M USD +101%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%